{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:16Z","timestamp":1792787296296,"version":"4.5.0"},"reference-count":134,"publisher":"BMJ","funder":[{"name":"CIBERONC Fund","award":["CB21\/12\/00121"],"award-info":[{"award-number":["CB21\/12\/00121"]}]},{"name":"NIH","award":["K12CA270377"],"award-info":[{"award-number":["K12CA270377"]}]},{"name":"NIH","award":["L30CA284403"],"award-info":[{"award-number":["L30CA284403"]}]},{"name":"NIH","award":["U01CA200468"],"award-info":[{"award-number":["U01CA200468"]}]},{"name":"NIH","award":["U24CA274274"],"award-info":[{"award-number":["U24CA274274"]}]},{"name":"NIH","award":["U54CA274371"],"award-info":[{"award-number":["U54CA274371"]}]},{"name":"Spanish Ministry of Sciences and Innovation","award":["PID2024-160242NB-I00"],"award-info":[{"award-number":["PID2024-160242NB-I00"]}]},{"DOI":"10.13039\/100002135","name":"Hirshberg Foundation for Pancreatic Cancer Research","doi-asserted-by":"publisher","award":["Seed Grant (HF-2024-29)"],"award-info":[{"award-number":["Seed Grant (HF-2024-29)"]}],"id":[{"id":"10.13039\/100002135","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Carmen Delgado\/Miguel P\u00e9rez Mateo Grants of the \u201cAsociaci\u00f3n Cancer de P\u00e1ncreas\u201d","id":[{"id":"https:\/\/ror.org\/04r9z3492","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,9,7]]},"abstract":"<jats:p>Metastatic pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid cancers, portending poor patient outcomes due to challenges in precise diagnosis and therapeutic resistance. Extensive molecular heterogeneity of metastatic tumours and their frequent evasion from clinical detection represent critical bottlenecks in disease management. Despite substantial research efforts, optimal clinical management remains an ongoing challenge. In this review, we outline the current understanding of metastatic pancreatic cancer, including its clinical features in patients. Emerging evidence highlights the pivotal roles of dynamic interactions between cancer cells and organ-specific and niche-specific microenvironments during metastatic spread. We further summarise the known molecular characteristics of metastatic PDAC and the preclinical models developed in pancreatic cancer research for functional interrogation. Finally, based on the current knowledge of this disease, we discuss existing limitations and future opportunities for advancing precision oncology approaches. These efforts may open promising avenues for the development of more effective clinical strategies aimed at mitigating metastasis in PDAC.<\/jats:p>","DOI":"10.1136\/gutjnl-2025-336334","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:31:08Z","timestamp":1790523068000},"page":"gutjnl-2025-336334","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Metastatic pancreatic cancer: from human disease to preclinical modelling"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct06593431","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-7875","authenticated-orcid":false,"given":"Jimin","family":"Min","sequence":"first","affiliation":[{"name":"Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York City, New York, USA"},{"name":"Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Liaki","sequence":"additional","affiliation":[{"name":"Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Y","family":"Yu","sequence":"additional","affiliation":[{"name":"Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York City, New York, USA"},{"name":"Division of Hematology and Medical Oncology, Department of Internal Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3891-046X","authenticated-orcid":false,"given":"Carmen","family":"Guerra","sequence":"additional","affiliation":[{"name":"Experimental Oncology Group, Tumor Biology Program, Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO), Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Cancer (CIBERONC), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-9978","authenticated-orcid":false,"given":"Anirban","family":"Maitra","sequence":"additional","affiliation":[{"name":"Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York City, New York, USA"},{"name":"Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York City, New York, USA"},{"name":"Department of Pathology, New York University Grossman School of Medicine, NYU Langone Health, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092410202374000_gutjnl-2025-336334v1.1","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"2026092410202374000_gutjnl-2025-336334v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00261-2"},{"key":"2026092410202374000_gutjnl-2025-336334v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2014.10.001"},{"key":"2026092410202374000_gutjnl-2025-336334v1.4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"2026092410202374000_gutjnl-2025-336334v1.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923"},{"key":"2026092410202374000_gutjnl-2025-336334v1.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13027"},{"key":"2026092410202374000_gutjnl-2025-336334v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30974-0"},{"key":"2026092410202374000_gutjnl-2025-336334v1.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0858-1","article-title":"Tumor microenvironment participates in metastasis of pancreatic cancer","volume":"17","author":"Ren","year":"2018","journal-title":"Mol Cancer"},{"key":"2026092410202374000_gutjnl-2025-336334v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01914-4"},{"key":"2026092410202374000_gutjnl-2025-336334v1.10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-025-02265-0","article-title":"Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasis","volume":"10","author":"Liu","year":"2025","journal-title":"Sig Transduct Target Ther"},{"key":"2026092410202374000_gutjnl-2025-336334v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/nature19823"},{"key":"2026092410202374000_gutjnl-2025-336334v1.12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191945","article-title":"Experimental models of pancreas cancer: what has been the impact for precision medicine?","volume":"135","author":"Pantazopoulou","year":"2025","journal-title":"J Clin Invest"},{"key":"2026092410202374000_gutjnl-2025-336334v1.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.03.002"},{"key":"2026092410202374000_gutjnl-2025-336334v1.14","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0017"},{"key":"2026092410202374000_gutjnl-2025-336334v1.15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7864"},{"key":"2026092410202374000_gutjnl-2025-336334v1.16","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.21037\/tcr-21-169","article-title":"The clinical application of 18F-FDG PET\/CT in pancreatic cancer: a narrative review","volume":"10","author":"Pu","year":"2021","journal-title":"Transl Cancer Res"},{"key":"2026092410202374000_gutjnl-2025-336334v1.17","doi-asserted-by":"crossref","first-page":"102374","DOI":"10.1016\/j.gassur.2026.102374","article-title":"Radiomics for early detection of pancreatic cancer: a systematic review and meta-analysis","volume":"30","author":"Alidina","year":"2026","journal-title":"J Gastrointest Surg"},{"key":"2026092410202374000_gutjnl-2025-336334v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02640-w"},{"key":"2026092410202374000_gutjnl-2025-336334v1.19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ueg2.12723","article-title":"Artificial Intelligence in Pancreatic Imaging: A Systematic Review","volume":"13","author":"Podin\u0103","year":"2025","journal-title":"United European Gastroenterol J"},{"key":"2026092410202374000_gutjnl-2025-336334v1.20","doi-asserted-by":"crossref","unstructured":"Mukherjee S , Antony A , Patnam NG , et al . Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability. Gut 2026. doi:10.1136\/gutjnl-2025-337266","DOI":"10.1136\/gutjnl-2025-337266"},{"key":"2026092410202374000_gutjnl-2025-336334v1.21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-334237"},{"key":"2026092410202374000_gutjnl-2025-336334v1.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304369"},{"key":"2026092410202374000_gutjnl-2025-336334v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01366-1"},{"key":"2026092410202374000_gutjnl-2025-336334v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/nature16965"},{"key":"2026092410202374000_gutjnl-2025-336334v1.25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031435","article-title":"KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer","volume":"8","author":"Waters","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026092410202374000_gutjnl-2025-336334v1.26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2026.01.001","article-title":"Emerging landscape of KRAS inhibitors in cancer treatment","volume":"44","author":"Riedl","year":"2026","journal-title":"Cancer Cell"},{"key":"2026092410202374000_gutjnl-2025-336334v1.27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2605555","article-title":"Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer","volume":"395","author":"O\u2019Reilly","year":"2026","journal-title":"N Engl J Med"},{"key":"2026092410202374000_gutjnl-2025-336334v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3398"},{"key":"2026092410202374000_gutjnl-2025-336334v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0566-9"},{"key":"2026092410202374000_gutjnl-2025-336334v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.11.017"},{"key":"2026092410202374000_gutjnl-2025-336334v1.31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-3050"},{"key":"2026092410202374000_gutjnl-2025-336334v1.32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1272"},{"key":"2026092410202374000_gutjnl-2025-336334v1.33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-1164"},{"key":"2026092410202374000_gutjnl-2025-336334v1.34","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-24-0177"},{"key":"2026092410202374000_gutjnl-2025-336334v1.35","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0740"},{"key":"2026092410202374000_gutjnl-2025-336334v1.36","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/S1470-2045(25)00714-4","article-title":"The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer","volume":"27","author":"Leonhardt","year":"2026","journal-title":"Lancet Oncol"},{"key":"2026092410202374000_gutjnl-2025-336334v1.37","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.suc.2024.04.009","article-title":"The Role of Surgery in \u201cOligometastatic\u201d Pancreas Cancer","volume":"104","author":"Hewitt","year":"2024","journal-title":"Surg Clin North Am"},{"key":"2026092410202374000_gutjnl-2025-336334v1.38","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1245\/s10434-024-15129-8","article-title":"Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability","volume":"31","author":"Koti","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026092410202374000_gutjnl-2025-336334v1.39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1200\/JCO.2024.42.3_suppl.603","article-title":"Addition of metastasis-directed therapy to standard-of-care systemic therapy for oligometastatic pancreatic ductal adenocarcinoma (EXTEND): Results of a multicenter, randomized phase II trial","volume":"42","author":"Ludmir","year":"2024","journal-title":"JCO"},{"key":"2026092410202374000_gutjnl-2025-336334v1.40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.7188"},{"key":"2026092410202374000_gutjnl-2025-336334v1.41","doi-asserted-by":"crossref","first-page":"45649","DOI":"10.18632\/oncotarget.9861","article-title":"Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis\u2014a case control study","volume":"7","author":"Decoster","year":"2016","journal-title":"Oncotarget"},{"key":"2026092410202374000_gutjnl-2025-336334v1.42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.pan.2021.01.014","article-title":"The impact of different metastatic patterns on survival in patients with pancreatic cancer","volume":"21","author":"He","year":"2021","journal-title":"Pancreatology"},{"key":"2026092410202374000_gutjnl-2025-336334v1.43","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jhbp.1127","article-title":"Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis","volume":"29","author":"Homma","year":"2022","journal-title":"J Hepato Biliary Pancreat"},{"key":"2026092410202374000_gutjnl-2025-336334v1.44","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02363-6"},{"key":"2026092410202374000_gutjnl-2025-336334v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08927-x"},{"key":"2026092410202374000_gutjnl-2025-336334v1.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02345-5"},{"key":"2026092410202374000_gutjnl-2025-336334v1.47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s43018-024-00881-3","article-title":"Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer","volume":"6","author":"Link","year":"2025","journal-title":"Nat Cancer"},{"key":"2026092410202374000_gutjnl-2025-336334v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/nature09515"},{"key":"2026092410202374000_gutjnl-2025-336334v1.49","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3764"},{"key":"2026092410202374000_gutjnl-2025-336334v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/S41588-018-0165-1"},{"key":"2026092410202374000_gutjnl-2025-336334v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/nature09460"},{"key":"2026092410202374000_gutjnl-2025-336334v1.52","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1158\/0008-5472.CAN-25-1117","article-title":"Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer","volume":"86","author":"Jim\u00e9nez-S\u00e1nchez","year":"2026","journal-title":"Cancer Res"},{"key":"2026092410202374000_gutjnl-2025-336334v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)49915-0"},{"key":"2026092410202374000_gutjnl-2025-336334v1.54","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0094"},{"key":"2026092410202374000_gutjnl-2025-336334v1.55","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162024"},{"key":"2026092410202374000_gutjnl-2025-336334v1.56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40727-7"},{"key":"2026092410202374000_gutjnl-2025-336334v1.57","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02003-0","article-title":"Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications","volume":"23","author":"Park","year":"2024","journal-title":"Mol Cancer"},{"key":"2026092410202374000_gutjnl-2025-336334v1.58","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113012","article-title":"Primary and metastatic cellular landscapes in human pancreatic cancer","volume":"28","author":"Steele","year":"2025","journal-title":"iScience"},{"key":"2026092410202374000_gutjnl-2025-336334v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1131-x"},{"key":"2026092410202374000_gutjnl-2025-336334v1.60","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3753"},{"key":"2026092410202374000_gutjnl-2025-336334v1.61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41388-020-01518-2","article-title":"Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma","volume":"40","author":"Nimmakayala","year":"2021","journal-title":"Oncogene"},{"key":"2026092410202374000_gutjnl-2025-336334v1.62","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1158\/0008-5472.CAN-24-3475","article-title":"PPAR\u03b4 Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer","volume":"85","author":"Parejo-Alonso","year":"2025","journal-title":"Cancer Res"},{"key":"2026092410202374000_gutjnl-2025-336334v1.63","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03075-7"},{"key":"2026092410202374000_gutjnl-2025-336334v1.64","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41586-025-09017-8","article-title":"PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer","volume":"643","author":"Rademaker","year":"2025","journal-title":"Nature"},{"key":"2026092410202374000_gutjnl-2025-336334v1.65","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2168"},{"key":"2026092410202374000_gutjnl-2025-336334v1.66","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00309-X"},{"key":"2026092410202374000_gutjnl-2025-336334v1.67","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1158703"},{"key":"2026092410202374000_gutjnl-2025-336334v1.68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0601273103"},{"key":"2026092410202374000_gutjnl-2025-336334v1.69","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1478706"},{"key":"2026092410202374000_gutjnl-2025-336334v1.70","doi-asserted-by":"crossref","unstructured":"English IA , Worth PJ , MacPherson-Hawthorne KA , et al . Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model. bioRxiv 2025. doi:10.1101\/2025.07.14.664767","DOI":"10.1101\/2025.07.14.664767"},{"key":"2026092410202374000_gutjnl-2025-336334v1.71","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1649"},{"key":"2026092410202374000_gutjnl-2025-336334v1.72","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42754"},{"key":"2026092410202374000_gutjnl-2025-336334v1.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.01.017"},{"key":"2026092410202374000_gutjnl-2025-336334v1.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.10.015"},{"key":"2026092410202374000_gutjnl-2025-336334v1.75","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1615"},{"key":"2026092410202374000_gutjnl-2025-336334v1.76","doi-asserted-by":"publisher","DOI":"10.1038\/nature25459"},{"key":"2026092410202374000_gutjnl-2025-336334v1.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.04.023"},{"key":"2026092410202374000_gutjnl-2025-336334v1.78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0908428107"},{"key":"2026092410202374000_gutjnl-2025-336334v1.79","doi-asserted-by":"crossref","DOI":"10.3390\/cells12222614","article-title":"Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Driven Pancreatic Cancer","volume":"12","author":"Sun","year":"2023","journal-title":"Cells"},{"key":"2026092410202374000_gutjnl-2025-336334v1.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2018.05.025"},{"key":"2026092410202374000_gutjnl-2025-336334v1.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.11.025"},{"key":"2026092410202374000_gutjnl-2025-336334v1.82","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s43018-025-01047-5","article-title":"SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence","volume":"6","author":"Tsanov","year":"2025","journal-title":"Nat Cancer"},{"key":"2026092410202374000_gutjnl-2025-336334v1.83","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184541","article-title":"Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice","volume":"13","author":"Tsesmelis","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026092410202374000_gutjnl-2025-336334v1.84","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3513"},{"key":"2026092410202374000_gutjnl-2025-336334v1.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108990"},{"key":"2026092410202374000_gutjnl-2025-336334v1.86","doi-asserted-by":"publisher","DOI":"10.1038\/nature16064"},{"key":"2026092410202374000_gutjnl-2025-336334v1.87","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.07.043"},{"key":"2026092410202374000_gutjnl-2025-336334v1.88","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3169"},{"key":"2026092410202374000_gutjnl-2025-336334v1.89","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325564"},{"key":"2026092410202374000_gutjnl-2025-336334v1.90","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp0684","article-title":"Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming","volume":"10","author":"Thielman","year":"2024","journal-title":"Sci Adv"},{"key":"2026092410202374000_gutjnl-2025-336334v1.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.05.011"},{"key":"2026092410202374000_gutjnl-2025-336334v1.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.01.012"},{"key":"2026092410202374000_gutjnl-2025-336334v1.93","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717802115"},{"key":"2026092410202374000_gutjnl-2025-336334v1.94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.03.009"},{"key":"2026092410202374000_gutjnl-2025-336334v1.95","doi-asserted-by":"crossref","unstructured":"Galv\u00e1n-del-Rey A , L\u00f3pez-Gil JC , Archibugi L , et al . Diet-induced macrophage-driven inflammation fuels pancreatic plasticity and aggressiveness. bioRxiv 2026;2026. doi:10.64898\/2026.02.10.703309","DOI":"10.64898\/2026.02.10.703309"},{"key":"2026092410202374000_gutjnl-2025-336334v1.96","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1177"},{"key":"2026092410202374000_gutjnl-2025-336334v1.97","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1134"},{"key":"2026092410202374000_gutjnl-2025-336334v1.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.10.010"},{"key":"2026092410202374000_gutjnl-2025-336334v1.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115652"},{"key":"2026092410202374000_gutjnl-2025-336334v1.100","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.748631","article-title":"Pre-clinical Models of Metastasis in Pancreatic Cancer","volume":"9","author":"Miquel","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026092410202374000_gutjnl-2025-336334v1.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188554"},{"key":"2026092410202374000_gutjnl-2025-336334v1.102","doi-asserted-by":"crossref","first-page":"102021","DOI":"10.1016\/j.xpro.2022.102021","article-title":"An intrasplenic injection model of pancreatic cancer metastasis to the liver in mice","volume":"4","author":"O\u2019Brien","year":"2023","journal-title":"STAR Protocols"},{"key":"2026092410202374000_gutjnl-2025-336334v1.103","doi-asserted-by":"crossref","first-page":"102696","DOI":"10.1016\/j.xpro.2023.102696","article-title":"Protocol for generating lung and liver metastasis in mice using models that bypass intravasation","volume":"5","author":"L\u00fccke","year":"2024","journal-title":"STAR Protocols"},{"key":"2026092410202374000_gutjnl-2025-336334v1.104","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11605-020-04681-9","article-title":"An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence","volume":"25","author":"Giri","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"2026092410202374000_gutjnl-2025-336334v1.105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.01.066"},{"key":"2026092410202374000_gutjnl-2025-336334v1.106","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-12104-0","article-title":"Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia","volume":"24","author":"Spadafora","year":"2024","journal-title":"BMC Cancer"},{"key":"2026092410202374000_gutjnl-2025-336334v1.107","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114224"},{"key":"2026092410202374000_gutjnl-2025-336334v1.108","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-295","article-title":"Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung","volume":"10","author":"Kalinina","year":"2010","journal-title":"BMC Cancer"},{"key":"2026092410202374000_gutjnl-2025-336334v1.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109443"},{"key":"2026092410202374000_gutjnl-2025-336334v1.110","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpa.0000175176.40045.0f"},{"key":"2026092410202374000_gutjnl-2025-336334v1.111","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-1166"},{"key":"2026092410202374000_gutjnl-2025-336334v1.112","doi-asserted-by":"publisher","DOI":"10.1016\/J.CCELL.2023.12.002"},{"key":"2026092410202374000_gutjnl-2025-336334v1.113","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012010","article-title":"FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer","volume":"12","author":"Zaghdoudi","year":"2020","journal-title":"EMBO Mol Med"},{"key":"2026092410202374000_gutjnl-2025-336334v1.114","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/1878-0261.13442","article-title":"Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways","volume":"17","author":"Chang","year":"2023","journal-title":"Mol Oncol"},{"key":"2026092410202374000_gutjnl-2025-336334v1.115","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16418"},{"key":"2026092410202374000_gutjnl-2025-336334v1.116","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01203-1","article-title":"Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma","volume":"14","author":"Pan","year":"2021","journal-title":"J Hematol Oncol"},{"key":"2026092410202374000_gutjnl-2025-336334v1.117","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333638"},{"key":"2026092410202374000_gutjnl-2025-336334v1.118","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.182766","article-title":"Targeting heterogeneous tumor microenvironments in pancreatic cancer mouse models of metastasis by TGF-\u03b2 depletion","volume":"9","author":"Chen","year":"2024","journal-title":"JCI Insight"},{"key":"2026092410202374000_gutjnl-2025-336334v1.119","first-page":"596","article-title":"Neutrophil extracellular traps promote liver micrometastasis in pancreatic ductal adenocarcinoma via the activation of cancer\u2011associated fibroblasts","volume":"56","author":"Takesue","year":"2020","journal-title":"Int J Oncol"},{"key":"2026092410202374000_gutjnl-2025-336334v1.120","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322744"},{"key":"2026092410202374000_gutjnl-2025-336334v1.121","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1368603","article-title":"The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma","volume":"7","author":"Lenk","year":"2017","journal-title":"Oncoimmunology"},{"key":"2026092410202374000_gutjnl-2025-336334v1.122","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03201-w","article-title":"CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment","volume":"43","author":"Tao","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"2026092410202374000_gutjnl-2025-336334v1.123","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3274467","article-title":"SEMA5A-PLXNB3 Axis Promotes PDAC Liver Metastasis Outgrowth through Enhancing the Warburg Effect","volume":"2023","author":"Wang","year":"2023","journal-title":"J Immunol Res"},{"key":"2026092410202374000_gutjnl-2025-336334v1.124","doi-asserted-by":"crossref","first-page":"215751","DOI":"10.1016\/j.canlet.2022.215751","article-title":"Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis","volume":"548","author":"He","year":"2022","journal-title":"Cancer Lett"},{"key":"2026092410202374000_gutjnl-2025-336334v1.125","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-19-3872","article-title":"Correction: Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN\/PI3K\u03b3 to Promote Pancreatic Cancer Metastasis","volume":"80","author":"Wang","year":"2020","journal-title":"Cancer Res"},{"key":"2026092410202374000_gutjnl-2025-336334v1.126","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3340"},{"key":"2026092410202374000_gutjnl-2025-336334v1.127","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-0256"},{"key":"2026092410202374000_gutjnl-2025-336334v1.128","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s43018-024-00751-y","article-title":"Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis","volume":"5","author":"Astuti","year":"2024","journal-title":"Nat Cancer"},{"key":"2026092410202374000_gutjnl-2025-336334v1.129","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41416-019-0595-2","article-title":"Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages","volume":"121","author":"Chen","year":"2019","journal-title":"Br J Cancer"},{"key":"2026092410202374000_gutjnl-2025-336334v1.130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41771-z"},{"key":"2026092410202374000_gutjnl-2025-336334v1.131","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146133","article-title":"DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis","volume":"6","author":"Deng","year":"2021","journal-title":"JCI Insight"},{"key":"2026092410202374000_gutjnl-2025-336334v1.132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.983116","article-title":"GJB3 promotes pancreatic cancer liver metastasis by enhancing the polarization and survival of neutrophil","volume":"13","author":"Huo","year":"2022","journal-title":"Front Immunol"},{"key":"2026092410202374000_gutjnl-2025-336334v1.133","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2212"},{"key":"2026092410202374000_gutjnl-2025-336334v1.134","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00297","article-title":"Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis","volume":"11","author":"Ireland","year":"2020","journal-title":"Front Immunol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-336334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:31:17Z","timestamp":1790523077000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-336334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":134,"alternative-id":["10.1136\/gutjnl-2025-336334"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-336334","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}